CPH creso pharma limited
Add to My Watchlist 0.00% ! 0.9¢

Creso Pharma (ASX:CPH) shares jump on record revenue growth

  1. TheMarketOnline
    7,927 Posts.
    lightbulb Created with Sketch. 1230
    clock Created with Sketch.
    01/07/21
    11:29
    Post #: 54203015
    • Creso Pharma (CPH) has reported its second consecutive quarter of record revenue growth, reaching just over $1.7 million in the quarter ending June 30
    • This is a 24 per cent increase over the last quarter and a 451 per cent increase over the previous corresponding period
    • The growth has come from strong demand for Creso's animal and human health CBD products as well as craft cannabis products from its Canadian subsidiary

    Read the Full Article on The Market Herald here
    CPH Price at posting: 14.5¢ Sentiment: None Disclosure: Not Held
    Likes Created with Sketch. 6  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

RMX Red Mountain Secures Utah Antimony Project in United States
right-arrow Created with Sketch.
NEWS Locksley significantly enlarges exploration program after historical discovery
right-arrow Created with Sketch.
NEWS Where the Australian property market resurgence is heading and why it matters now
right-arrow Created with Sketch.
AII Becoming the largest conflict-free tungsten supplier in the world
right-arrow Created with Sketch.
FBM Assays confirm strong gold anomalism at Canyon within Miriam Project
right-arrow Created with Sketch.
NEWS CLEO receives positive FDA feedback supporting ovarian cancer test pathway
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.